ArticleACS nano2024

A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.

Jessalyn J Baljon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.